US Stock MarketDetailed Quotes

THTX Theratechnologies

Watchlist
  • 1.2200
  • -0.0400-3.17%
Close May 10 16:00 ET
56.10MMarket Cap-2103P/E (TTM)

About Theratechnologies Company

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.

Company Profile

SymbolTHTX
Company NameTheratechnologies
Listing DateOct 10, 2019
Founded1993
CEOMr. Paul Levesque
MarketNASDAQ
Employees58
Securities TypeOrdinary Shares
Fiscal Year Ends11-30
Address2015 Peel Street,11th floor
CityMontréal
ProvinceQuébec
CountryCanada
Zip CodeH3A 1T8
Phone1-514-336-7800
Websitehttp://www.theratech.com

Company Executives

  • Name
  • Position
  • Salary
  • Paul Levesque
  • Director, President and Chief Executive Officer
  • 1.90M
  • Philippe Dubuc
  • Senior Vice President and Chief Financial Officer
  • 654.50K
  • Dr. Christian Marsolais, PhD
  • Senior Vice President and Chief Medical Officer
  • 656.79K
  • John Leasure
  • Global Commercial Officer
  • 604.30K
  • Marie-Noel Colussi
  • Vice President, Finance
  • --
  • Andre Dupras
  • Vice President, Human Resources
  • --
  • Dawn Svoronos
  • Chairman of the Board
  • 152.52K
  • Frank A. Holler
  • Independent Director
  • 76.26K
  • Alain Trudeau
  • Independent Director
  • 83.67K
  • Andrew T. Molson
  • Independent Director
  • 74.78K
  • Dale MacCandlish Weil
  • Independent Director
  • 77.74K
  • Joseph P. Arena
  • Independent Director
  • 72.44K
  • Gerald A. Lacoste
  • Independent Director
  • 83.67K
  • Jocelyn Lafond
  • General Counsel and Corporate Secretary
  • 468.88K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg